Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0002011962-24-000001
Filing Date
2024-02-14
Accepted
2024-02-14 15:39:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 8265
  Complete submission text file 0002011962-24-000001.txt   9985
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Subject) CIK: 0001005286 (see all company filings)

EIN.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0528
Type: SCHEDULE 13G | Act: 34 | File No.: 005-45181 | Film No.: 24636998
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 41B NORTH VILLAGE ROAD ROCKVILLE CENTRE NY 11570
Business Address 41B NORTH VILLAGE ROAD ROCKVILLE CENTRE NY 11570 917-306-0461
LW CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0002011962 (see all company filings)

EIN.: 810760259 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SCHEDULE 13G